Angiodynamics to report fiscal 2024 second quarter financial results on january 5, 2024

Latham, n.y.--(business wire)--angiodynamics, inc. (nasdaq: ango), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients, today announced that it will report financial results for the second quarter of fiscal year 2024 before the market open on friday, january 5, 2024. the company's management will host a conference call at 8:00 a.m. et the same.
ANGO Ratings Summary
ANGO Quant Ranking